Equity
€157,580 ▲ 2.4%
VIE paid out €28,275 in dividends. That is 67% of the 2025 profit.
VIE
Lifetime
5 annual accounts with figures on one time axispeak €117,700 (2025)
€117,700▲ 34.6%
peak €46,523 (2021)
€42,038▲ 57.9%
peak €157,580 (2025)
€157,580▲ 2.4%
€786,708▲ 1.9%
Board1 name since 2020
1 directorVAN EESSEN Inge
Documentsfilings and deeds
29-06-202632 days before the deadline
2025micro format
Gross margin from €87,439 to €117,700Result from €26,616 to €42,038Dividend €28,275Cash from €119,352 to €161,883
Key points
from the 2025 annual accountsTurnover
≈ €240,000 estimated
The micro format states no turnover.
Debts
€786,708 83% of the balance sheet
Financial debts 82%Suppliers 3%Taxes and wages 0%Other 15%
Of this, €135,938 falls due within a year.
Filings
5 annual accounts since 2021
The last five annual accounts were filed 3 to 36 days before the end of the period.
Starting capital
€2,500 100 shares
Position in the sector
16.7%
Lower solvency than 82% of companies in human health. Sector median 63.0% · 20,767 companies.
Checked score
91
Excellent
Financially stronger than 30% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.2%▲ +0.1 percentage points vs 05-2025
07-2025: 0.2%● unchanged vs 06-2025highest value
08-2025: 0.1%▼ -0.1 percentage points vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.2%▲ +0.1 percentage points vs 04-2026
06-2026: 0.2%● unchanged vs 05-2026
07-2026: 0.1%▼ -0.1 percentage points vs 06-2026
08-2026: 0.1%● unchanged vs 07-2026
09-2026: 0.1%● unchanged vs 08-2026
10-2026: < 0.1%▼ -0.1 percentage points vs 09-2026lowest value
11-2026: < 0.1%● unchanged vs 10-2026lowest value
Financial strengthAverage
Score breakdown
lowers risk
Sector: Human health activities (NACE 86)
Size: total assets €944,287
Figures for financial year 2025 (filed on 29-06-2026)
Liquidity: current ratio 1.21, cash €161,883
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 18% of them on solvency, 49% on liquidity, 10% on profitability and 42% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 2,372 companies had the same profile as VIE has now. Each dot stands for 6 companies, two years later.
96.6%
were still trading
1.4%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of VIE itself is lower: < 0.1% within 12 months. It rests on far more data about VIE than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,372 companies, not a prediction for VIE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €14,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.21 (1.26 in 2024), below the usual 1.5. Short-term debt is 14.4% and cash 17.1% of total assets. 83.3% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 18% of 20767 sector peers (2025).
NBB · sector comparisonPosition among 20767 sector peers
Solvency
better than 18%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
32 days early
2024
24 days early
2023
36 days early
2022
3 days early
2021
12 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 5 accounts on average 21 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 7 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0749646979
Registered office moved from Holsbeek to Leuven
New registered office: Kalkstraat 18, 3000 Leuven · Previous registered office: Pleinstraat 50, 3220 Holsbeek · Board meeting of 24-05-2024 · Gazette deed
Incorporation
Founding capital of €2,500, 100 shares · Founder: VAN EESSEN Inge · Appointment: VAN EESSEN Inge (director) · published on 03-07-2020 · Gazette deed
First establishment
Kalkstraat 18, Leuven
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| VIE Leuven | €944,287 | €117,700 | 16.7% | - |
| KINEUM Zedelgem | €858,044 | €140,207 | 16.5% | - |
| Kinepraktijk Ruggeveld Antwerp | €770,082 | €106,968 | 12.2% | - |
| SMD FEXHE Fexhe-le-Haut-Clocher | €996,849 | €96,603 | 8.4% | 0.5 |
| IVIC Antwerp | €956,707 | €100,085 | 8.2% | - |
| Clijmans Kinesitherapie Beerse | €879,769 | €113,661 | 33.7% | - |
| LOUIS CANT Bruges | €810,330 | €135,855 | 24.2% | - |
These companies have the same main activity as VIE: physiotherapy (NACE 86951). They are comparable in size and age: total assets between €770,000 and €997,000, founded between 2018 and 2021.
Official details
Source: KBO- Status
- Active since 01-07-2020Normal situation
- Activity
- PhysiotherapyNACE 86951
- Establishment unit
- 2.304.234.1093000 Leuven, since 01-07-2020
- Financial year end
- 31 December
- Peppol
- Reachable since 22-04-2026
Annual accounts 2025
- €944,287▲ 2.0%
- Filing
- Filed on 29-06-2026, 32 days before the end of the filing period
Insights on VIE
VIE files the micro format. That format states no turnover. The gross margin rose from €63,026 in 2021 to €117,700 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about VIE
- What is the company number of VIE?
- The company number of VIE is 0749.646.979. The VAT number is the same number with BE in front: BE 0749.646.979.
- Where is VIE based?
- The registered office is at Kalkstraat 18, 3000 Leuven.Company details
- What does VIE do?
- According to the KBO register, the main activity is physiotherapy (NACE 86951).
- What is the legal form of VIE?
- VIE is a private limited company (BV).
- When was VIE founded?
- VIE was founded on 01-07-2020.
- Is VIE still active?
- Yes, VIE is an active enterprise in the KBO register.
- What is the turnover of VIE?
- The turnover in financial year 2025 is ≈ €240,000. This figure is estimated from the gross margin of €117,700 and 80 comparable companies (NACE 86). It probably lies between €180,000 and €290,000.Financials
- Is VIE profitable?
- In financial year 2025, VIE made a profit of €42,038.
- Where can I find the annual accounts of VIE?
- VIE filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of VIE due?
- VIE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.